Chaperon Appoints Executive Director Yoon Myung-jin as New CFO

[Asia Economy Reporter Hyungsoo Park] Bio venture company Shaperon announced on the 15th that it has recruited Executive Director Yoon Myung-jin as Chief Financial Officer (CFO).

Shaperon plans to actively promote a successful listing on the KOSDAQ market by recruiting a CFO and will focus all efforts on securing growth momentum.

Executive Director Yoon Myung-jin graduated from Korea University and has handled investment, initial public offering (IPO), mergers and acquisitions (M&A) advisory, and professional consulting at LG Life Sciences and Samil Accounting Corporation. He is a financial expert with over 20 years of experience in the bio and healthcare fields, having held key positions in new business development and strategic planning.

Executive Director Yoon said, "Shaperon is a promising bio venture company with core technologies capable of targeting overseas markets. I will combine my experience and know-how as an investment expert and IPO specialist to promote Shaperon's listing and its substantial growth as a global bio company."

Shaperon CEO Lee Myung-se explained, "Yoon Myung-jin's professional consulting and investment experience in the bio and healthcare fields, as well as his extensive experience in business development and strategic planning, will be a great asset for Shaperon as it pursues its listing."